Brand:
Dragon Pharma, Europe
Manufacturer:
Dragon Pharma, Europe
Dosage Info:
<div class="tab-pane fade" id="offer-tabbody--dosage-and-usage" role="tabpanel">
<section class="tab-panel" id="panel-usage">
<h2>Dosage & Usage Guidelines</h2>
<p>Administered via weekly subcutaneous injections, Survodutide is typically started at a low dose and titrated upwards over several weeks. This approach minimizes gastrointestinal discomfort while achieving optimal metabolic outcomes. Typical protocols escalate from 0.6 mg/week up to 4.8 mg/week across a 16–20 week ramp-up phase, followed by a maintenance cycle.</p>
<p>Dosage schedules should be individualized and supervised by a medical professional, especially for patients with comorbidities.</p>
<h3>Example Survodutide Cycle</h3>
<p>A standard example cycle begins with:</p>
<ul>
<li>Weeks 1–4: 0.6 mg/week</li>
<li>Weeks 5–8: 1.2–2.4 mg/week</li>
<li>Weeks 9–12: 3.0–3.6 mg/week</li>
<li>Weeks 13–16: 4.8 mg/week (max dose)</li>
<li>Weeks 17–24: Maintain at 4.8 mg/week</li>
</ul>
<p>Clinical benefits are most notable when Survodutide is paired with a caloric deficit and light physical activity.</p>
<h3>Possible Adverse Effects</h3>
<p>Survodutide is well tolerated by most users. Initial side effects can include <a href="https://medlineplus.gov/fatigue.html" rel="noopener" target="_blank">fatigue</a>, mild <a href="https://www.mayoclinic.org/diseases-conditions/dizziness/symptoms-causes/syc-20371787" rel="noopener" target="_blank">dizziness</a>, and gastrointestinal symptoms such as nausea or bloating. These effects usually subside as the body adapts.</p>
<p>More serious side effects are rare but may include kidney strain or cardiovascular impacts in predisposed individuals. Periodic lab monitoring is advised, especially during prolonged use cycles.</p>
<h3>Is Survodutide Right for You?</h3>
<p>Survodutide may be a strong addition to any advanced fat-loss protocol. It's ideal for users looking to amplify body recomposition or support weight control where traditional strategies fall short.</p>
<p>Survodutide is available in our <a href="https://www.dragonpharma.net/peptides-414">GLP-1 agonists category</a>, alongside other peptides designed to enhance fat metabolism and appetite regulation.</p>
<h3>Why Choose Dragon Pharma Survodutide?</h3>
<p>Dragon Pharma is known for delivering research-backed peptides with high purity and consistent dosing. Whether you're an athlete cutting for a show or managing long-term weight loss, this is one of the most potent metabolic enhancers on the market.</p>
<p>Browse more <a href="/">Dragon Pharma gear</a> trusted by athletes and biohackers worldwide.</p>
</section>
</div>
Technical Details
Peptide Type
Lipidated Synthetic Peptide
Peptide Profile
Glucagon-Derived Peptide Analogue
Structural Profile
Long-Acting Acylated Peptide
Molecular Formula
C₁₉₂H₂₈₉N₄₇O₆₁
Molecular Weight
4232 g/mol
Receptor Targets
GCGR + GLP-1R
Pharmacologic Profile
Dual Glucagon / GLP-1 Receptor Agonist
Development Code
BI 456906
Development Status
Investigational